Expert: CSL to closely watch Grifols-Talecris deal

06/8/2010 | Business Spectator (Australia)

CSL's Brian McNamee is expected to closely watch the move by Spanish firm Grifols to acquire Talecris and its possible effect on his company, Stephen Bartholomeusz writes in this Business Spectator commentary. The finalization of the acquisition could mean that the intravenous immunoglobulin market would be dominated by three key players with almost similar market shares, namely Baxter, CSL and Grifols, Bartholomeusz writes.

View Full Article in:

Business Spectator (Australia)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations